Lifetech Scientific Shenzhen Co.

Shenzhen, China

Lifetech Scientific Shenzhen Co.

Shenzhen, China
SEARCH FILTERS
Time filter
Source Type

Patent
Lifetech Scientific Shenzhen Co. | Date: 2017-08-16

An ablation catheter device (100) comprises a hollow catheter main body (102), an ablation mechanism (103) and a control mechanism (105). The ablation mechanism (103) comprises a support assembly (110) capable of being expanded and compressed radially, an end (120) and a plurality of modulation units. The support assembly (110) is provided between the distal end of the catheter main body (102) and the end (120). The modulation units are provided on the support assembly (110), and an axial through hole (122) is formed in the end (120). The control mechanism (105) comprises a drawing wire (104) and a limit unit (118) fixed on the drawing wire (104). The drawing wire (104) axially penetrates the catheter main body (102) and the through hole (122). The end (120) is provided between the support assembly (110) and the limit unit (118), and the outer diameter of the limit unit (118) is larger than the pore diameter of the through hole (122). The ablation catheter device (100) is suitable for a transfemoral coronary puncture intervention path, or is preferably suitable for a transradial coronary puncture intervention path. For some bent and complex artery blood vessels, the ablation catheter device (100) can reduce the adjustment and moving location difficulty in the blood vessels, avoid damages to the blood vessels as much as possible and improve the ablation effect.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2017-05-10

The present invention relates to an occluder (100), comprising a meshed occlusion body (1) provided with a cavity (103), and a proximal hub (2), as well as a locking member (10) and a stopping member (13) both of which are located in the cavity (103). The distal end of the locking member (10) is connected to the distal end of the occlusion body (1). The stopping member (13) is disposed at the proximal end of the locking member (10). The proximal occluder head (2) is provided with a locking hole (15) in communication with the cavity (103). The radial size of the stopping member (13) is slightly larger than the diameter of the locking hole (15). The radial size of the locking member (10) is smaller than the diameter of the locking hole (15), and at least one of the proximal occluder head (2) and the stopping member (13) is an elastic member. An occlusion device comprises the occluder (100), a hollow delivery mechanism (200) and a traction member (4). The distal end of the traction member (4) is detachably connected to the proximal end of the locking member (10) of the occluder (100) after extending through the distal end of the delivery mechanism (200). The occlusion device has a simple locking structure, and simplifies the manufacturing process and the locking operation.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2017-05-03

A bifurcated stent graft (10) comprises a body (100) and a side branch (200) that forms an acute angle with the body (100). The side branch (200) comprises a covering film (220) and a first bare stent (240) only disposed on the covering film (220). Part of the first bare stent (240) is positioned adjacent a boundary line (230) of the body (100) and the covering film (220) and is located in a vertex angle area (250) of the acute angle. Due to the fact that part of the first bare stent (240) is attached to the vertex angle area (250), after the stent (10) is released, the self-expanded part of the first bare stent (240) enables the vertex angle area (250) of the side branch (200) to be effectively supported, the covering film is not prone to shrinkage, and a leading wire can enter easily. Meanwhile, a special bare stent attached to the vertex angle area (250) does not need to be additionally disposed on the first bare stent (240), and thus the technology for preparing the bare stent is simplified; furthermore, the first bare stent (240) is only disposed on the side branch (200) and does not need to span the connecting part of the body (100) and the side branch (200), and thus the waveform can be shaped easily.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-11-09

The present invention relates to an implant conveying device, comprising a pusher (20), a control component (21), a connecting wire (11) and a control wire (4). The pusher (20), of which one end is connected to the control component (21), is provided with a tube cavity (6) and a lock hole (7) communicated with the tube cavity. One end of the control wire (4) is connected to the control component (21), and the other end thereof is driven by the control component to be movably accommodated in the tube cavity (6) of the pusher. One end of the connecting wire (11) is connected to the pusher (20) or to the control component (21), and the other end thereof is used for passing through an implant (1) and then entering the lock hole (7). The control wire (4) is driven by the control component (21) to pass through the connecting wire (11) to connect the implant (1) and the conveying device, or the control wire (4) is driven by the control component (21) to be disengaged from the connecting wire (11) to release the implant (1). By means of the conveying device, locking rings on instruments are removed, so that no redundant metal remains after the implant is implanted into the human body.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-11-02

The present invention relates to a drug coated balloon catheter, comprising a balloon and a drug coating covering the surface of the balloon; the drug coating comprises an active drug and a carrier; the active drug is paclitaxel, rapamycin, a paclitaxel derivative or rapamycin derivative; the carrier comprises an organic acid salt and polyalcohol; a mass ratio of the active drug to the carrier in the drug coating is 0.2 to 100, and a mass ratio of the organic acid salt to the polyalcohol is (0.2 to 5): 1. The organic acid salt and the polyalcohol in the drug coating jointly take effect to prevent the premature release of drugs before the balloon catheter is positioned at a target site, and to promote the drugs being quickly released from the surface of the balloon and absorbed by the target tissue, thus reducing drug loss during transmission, and also having a better drug transfer effect.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-09-07

The invention discloses an absorbable iron alloy stent, comprising an iron alloy substrate and a degradable polymer in contact with the surface of the substrate, in which the degradable polymer has a weight average molecular weight of more than or equal to 20,000 and less than or equal to 1,000,000 and a polydispersity index of more than 1.0 and less than or equal to 50. After the iron alloy stent is implanted into the body, the degradable polymer degrades to produce a carboxyl group. After the degradable stent is implanted into the human body, the effects of oxygen-consuming corrosion enable the stent both to mainly function as a mechanical support and then to degrade gradually, and the amount of hydrogen produced in the degradation process does not reach the level that can lead to a risk of air embolism.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-04-13

Disclosed is a manufacturing method of an iron-based alloy medical apparatus, comprising: nitriding the iron-based alloy preformed unit at 350-550C for 30- 100 minutes; and ion etching the iron-based alloy preformed unit with an ion etching time of 80-110% of the nitriding time. Ion nitriding and ion etching can be performed in situ in the same equipment using this manufacture method with high production efficiency, and in the ion nitriding and ion etching process, nitrogen atoms continuously permeate the preformed unit, making the time it takes for the medical apparatus to be absorbed by the human body and both the hardness and strength of the instrument surface achieve requirements.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-10-05

The present invention relates to a thoracic aortic covered stent (100), comprising a bare stent segment (110) and a covered stent segment (120). The bare stent segment (110) comprises a bare wave-shaped ring (111); the covered stent segment (120) has a lesser curvature side region (100c), a greater curvature side region (100a), and two opposite intermediate regions (100b) located between the lesser curvature side region (100c) and the greater curvature side region (100a) respectively; and the covered stent segment (120) comprises a first proximal wave-shaped ring (121). The stent (100) further comprises a first connecting member (131), a first side connecting member (132) and a second side connecting member (133) all connected to the bare wave-shaped ring (111) and the first proximal wave-shaped ring (121), wherein the first connecting member (131) is arranged in the lesser curvature side region (100c), and the first side connecting member (132) and the second side connecting member (133) are arranged in the two intermediate regions (100b) respectively. The stent (100) when located near the lesser curvature side (22) with a relatively small radius of curvature has a connecting assembly rigidly connecting the bare stent segment (110) and the covered stent segment (120), and through the constraints thereof, the bare stent segment (110) can be effectively prevented from overturning towards the vessel wall during the release process, so that the proximal end of the covered stent segment (120) is securely apposed to the wall, thereby avoiding the turnover effect.


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-11-02

The present invention relates to a steerable sheath tube (100) including a tube body (110), a traction mechanism (120) and a fixing and connecting mechanism (130). The traction mechanism (120) includes an anchor ring (121) and a traction wire (122). The anchor ring (121) is coaxially embedded in a distal elastic segment (111) of the tube body (110). The traction wire (122) is arranged in a side wall of the tube body (110), and extends along the axial direction of the tube body (110). The traction wire (122) includes a first segment and a second segment connected to each other, wherein the first segment is connected to the fixing and connecting mechanism (130) near a proximal end of the tube body (110), and the second segment hooks the anchor ring (121).


Patent
Lifetech Scientific Shenzhen Co. | Date: 2016-11-09

The present invention provides an aortic arch intraoperative stent, wherein the aortic arch intraoperative stent comprising a main body (17) and one to three branches (5, 6, 7). The aortic arch intraoperative stent connects several circular waveform rings together via a cover membrane (25) to form the main body (17) and the branches (5, 6, 7), wherein each circular waveform ring comprises a circular elastic wire formed through head-to-tail connection. In addition, the present invention also provides a manufacturing method for the aortic arch intraoperative stent, comprising the following steps of: providing a cover membrane mandrel (40); making an inner membrane; assembling circular waveform rings; making an outer membrane; suturing a proximal fabric (12); and suturing a distal fabric (13). The aortic arch intraoperative stent can automatically adapt to the vascular structure near the aortic arch of different patients, and the main body (17) in the aortic arch intraoperative stent maintains a sufficient radial support for the branches, thereby ensuring that the branches on the aortic arch intraoperative stent may safely enter branch vessels during surgery, and preventing the branches from slipping out of the corresponding branch vessels during and after surgery at the same time.

Loading Lifetech Scientific Shenzhen Co. collaborators
Loading Lifetech Scientific Shenzhen Co. collaborators